PT-141 is a metabolite of Melanotan 2 that differs by a single structural feature, and that difference shifts its receptor selectivity. It is a useful case study in how small modifications alter peptide pharmacology.

What Is PT-141?

PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide. Structurally it is Melanotan 2 with the C-terminal amide group replaced by a free carboxylic acid — it is in fact a metabolic product of Melanotan 2.

That single change is consequential. Where Melanotan 2 is a broad non-selective agonist across the melanocortin family, PT-141 shows relative preference for MC4R and notably reduced activity at MC1R, the subtype expressed on melanocytes.

How Researchers Understand Its Mechanism

MC4R is expressed predominantly in central nervous tissue, particularly hypothalamic regions, and is one of the most studied melanocortin receptors in neuronal signalling research. PT-141’s relative selectivity for this subtype makes it a more targeted tool than Melanotan 2 for studying MC4R-mediated signaling specifically.

Like other melanocortin receptor agonists, it signals principally through Gs and cyclic AMP. Research has characterised its binding affinity and functional potency across all five subtypes to establish the selectivity profile quantitatively, since “selective” is a relative rather than absolute description.

The Melanotan 2 and PT-141 pair is instructive: because they differ by one terminal modification, comparing them isolates the contribution of that group to receptor discrimination.

Areas of Scientific Investigation

Applications include MC4R receptor pharmacology, melanocortin subtype selectivity profiling, central signaling models, structure-activity relationship studies, and comparative work against non-selective reference ligands.

Why Purity and Verification Matter

Reproducibility in peptide research depends on knowing exactly what is in the vial. Sequence-related impurities, truncated fragments and residual synthesis reagents can all influence experimental outcomes, and two preparations nominally of the same compound can behave differently if purity differs. Independent HPLC and mass spectrometry testing establishes both identity and purity, which is why third-party verification is standard practice for research-grade material. All compounds referenced here are supplied as lyophilized powder at 99%+ purity with independent verification.

Summary

PT-141 is a cyclic heptapeptide and Melanotan 2 metabolite showing relative preference for MC4R over other melanocortin subtypes. Its value in research is as a comparatively selective probe of MC4R-mediated signaling. It is intended strictly for laboratory research.

Related Research Peptides

PT-141 10mg · Melanotan 2 10mg · Melanotan 1 10mg · KPV 10mg

For laboratory and research use only. Not for human or veterinary use, and not for diagnostic or therapeutic purposes.